Germany banned export of antibiotic drug cephalosporin from Dewas plant of Ranbaxy

Dec 5, 2014 11:30 IST

German Drug Regulatory Authority (GDRA) on 3 December 2014 decided to bar export of antibiotic drug cephalosporin from Ranbaxy Laboratories.

The move was announced after the Ranbaxy plant at Dewas in Madhya Pradesh failed to comply with standard manufacturing practices.

The GDRA issued a non-compliance report for the plant where Ranbaxy made the antibiotic, after an inspection in June 2014.

During the inspection, the GDRA found deficiencies related to operation of drug manufacturing rooms and procedures related to sterilisation of equipment at the Dewas site.

The Dewas factory and Ranbaxy’s other India-based plants are also barred from exporting to the United States after the U.S. Food and Drug Administration (FDA) inspections found those plants violated its standard manufacturing practices.

Ranbaxy gets more than half of its revenue from the United States. Germany accounted for 2 per cent of global sales in the 15-month period till March 2014.

Is this article important for exams ? Yes11 People Agreed

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK